These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 131665)

  • 1. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
    Björkholm M; Holm G; Mellstedt H; Pettersson D
    Clin Exp Immunol; 1975 Dec; 22(3):373-7. PubMed ID: 131665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H; Vogt W; Rühl U
    G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
    Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
    Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
    Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
    J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Johansson B
    Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
    van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
    Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of interleukin-2 and expression of tac antigen in Hodgkin disease.
    Joshi NN; Mukhopadhyay R; Advani SH; Gangal SG
    Cancer Detect Prev Suppl; 1987; 1():137-43. PubMed ID: 2825998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological aspects of Hodgkin's disease].
    Bianchini E
    Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
    Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
    J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
    Twomey JJ; Laughter AH; Farrow S; Douglass CC
    J Clin Invest; 1975 Aug; 56(2):467-75. PubMed ID: 125290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.